Terms And Conditions
  1. Home
  2. Terms And Conditions
Aroa Biosurgery Ltd (ASX: ARX): Focused on in...
By ACE Investors / 01 Nov 2024
Read More
Noxopharm Limited (ASX: NOX)...
By ACE Investors / 31 Oct 2024
Read More
Vitura Health Limited (ASX: VIT): Announced a...
By ACE Investors / 31 Oct 2024
Read More
Next Science Limited (ASX: NXS): The recently...
By ACE Investors / 30 Oct 2024
Read More
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD): A...
By ACE Investors / 23 Oct 2024
Read More
Mayne Pharma Group Ltd (ASX: MYX): Delivered ...
By ACE Investors / 18 Oct 2024
Read More
Percheron Therapeutics Limited (ASX: PER): C...
By ACE Investors / 15 Oct 2024
Read More
Pacific Smiles Group Limited (ASX: PSQ): High...
By ACE Investors / 15 Oct 2024
Read More
LIFE360 Inc. (ASX: 360): Remains on track to ...
By ACE Investors / 08 Oct 2024
Read More
CSL Limited (ASX: CSL) – Confident In Its D...
By ACE Investors / 08 Oct 2024
Read More
Compumedics Limited (ASX: CMP) – New and in...
By ACE Investors / 07 Oct 2024
Read More
Clinuvel Pharmaceuticals Limited (ASX: CUV): ...
By ACE Investors / 20 Sep 2024
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors